Discover our
White Paper and explore the fascinating journey of this molecule !

Click here to get our White Paper

HTL Biotechnology’s newly launched White Paper

To celebrate 90 years of this remarkable discovery, HTL Biotechnology recently launched its White Paper, which is an embodiment of our expertise and global leadership as a developer and manufacturer of pharmaceutical grade Hyaluronic Acid.

This 70-page book covers a range of topics related to Hyaluronic Acid, including:

  • The evolution of Hyaluronic Acid since its discovery, as well as its current and future applications in medicine and aesthetics.
  • The chemical structure of HA and its impact on biological functions such as hydration and healing.
  • Ongoing research to optimise HA's therapeutic potential.
  • The innovations surrounding HA that will shape its use in the future.

The history and evolution of a versatile molecule

Tracing the journey of Hyaluronic Acid starting from the laboratory to applications in medicine

1934

Discovery of HA by Karl Meyer and John Palmer

1966

First use in animal health in horses (arthropathy)

1972

First use in humans (osteoarthritis)

1979

First marketing authorisation in ophthalmology (cataracts)

1987

First approval by healthcare agencies in osteoarthritis indication

1990 onwards

Emergence of use in medical aesthetics and cosmetic procedures

Discover our solutions

Hyaluronic Acid (sodium hyaluronate)

Pharmaceutical Grade Hyaluronic Acid

Oligo HA

Ultra-low molecular weight Hyaluronic Acid

Have any
questions ?

Contact us